Prophylaxis and Treatment of Venous Thromboembolism in Cancer Patients A Review

被引:3
作者
Ansell, Jack E. [1 ]
机构
[1] Lenox Hill Hosp, Dept Med, New York, NY 10075 USA
来源
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 2009年 / 32卷 / 04期
关键词
cancer; venous thromboembolism; prophylaxis; treatment; MOLECULAR-WEIGHT HEPARIN; THROMBOSIS PROPHYLAXIS; ABDOMINAL-SURGERY; VEIN THROMBOSIS; BRAIN-TUMORS; PREVENTION; COMPLICATIONS; THROMBOPROPHYLAXIS; DALTEPARIN; THERAPY;
D O I
10.1097/COC.0b013e3181b01c06
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Thromboprophylaxis is underused in patients with cancer, despite the fact that malignancy is a serious risk factor for venous thromboembolism in this population. Major medical guidelines, including those published recently by the American College of Chest Physicians, the American Society of Clinical Oncology, and the National Comprehensive Cancer Network, recommend routine thromboprophylaxis for patients with cancer under certain situations. This review describes current recommendations for primary and secondary prophylaxis in patients with cancer.
引用
收藏
页码:S8 / S12
页数:5
相关论文
共 32 条
[1]   Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery [J].
Agnelli, G ;
Bergqvist, D ;
Cohen, AT ;
Gallus, AS ;
Gent, M .
BRITISH JOURNAL OF SURGERY, 2005, 92 (10) :1212-1220
[2]   Thromboprophylaxis rates in US medical centers: success or failure? [J].
Amin, A. ;
Stemkowski, S. ;
Lin, J. ;
Yang, G. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (08) :1610-1616
[3]   Risk factors for venous thromboembolism [J].
Anderson, FA ;
Spencer, FA .
CIRCULATION, 2003, 107 :I9-I16
[4]   Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. [J].
Bergqvist, D ;
Agnelli, G ;
Cohen, AT ;
Eldor, A ;
Nilsson, PE ;
Le Moigne-Amrani, A ;
Dietrich-Neto, F .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (13) :975-980
[5]   Underuse of venous thromboembolism prophylaxis for general surgery patients - Physician practices in the community hospital setting [J].
Bratzler, DW ;
Raskob, GE ;
Murray, CK ;
Bumpus, LJ ;
Piatt, DS .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (17) :1909-1912
[6]   Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study [J].
Cohen, Alexander T. ;
Tapson, Victor F. ;
Bergmann, Jean-Francois ;
Goldhaber, Samuel Z. ;
Kakkar, Ajay K. ;
Deslandes, Bruno ;
Huang, Wei ;
Zayaruzny, Maksim ;
Emery, Leigh ;
Anderson, Frederick A., Jr. .
LANCET, 2008, 371 (9610) :387-394
[7]   Prevention of venous thromboembolism [J].
Geerts, WH ;
Pineo, GF ;
Heit, JA ;
Bergqvist, D ;
Lassen, MR ;
Colwell, CW ;
Ray, JG .
CHEST, 2004, 126 (03) :338S-400S
[8]   Prevention of venous thromboembolism [J].
Geerts, William H. ;
Bergqvist, David ;
Pineo, Graham F. ;
Heit, John A. ;
Samama, Charles M. ;
Lassen, Michael R. ;
Colwell, Clifford W. .
CHEST, 2008, 133 (06) :381S-453S
[9]   Management of venous thromboembolism in patients with primary and metastatic brain tumors [J].
Gerber, DE ;
Grossman, SA ;
Streiff, MB .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (08) :1310-1318
[10]   A five-year, retrospective, comparison review of survival in neurosurgical patients diagnosed with venous thromboembolism and treated with either inferior vena cava filters or anticoagulants [J].
Ghanim, Amanda J. ;
Daskalakis, Constantine ;
Eschelman, David J. ;
Kraft, Walter K. .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2007, 24 (03) :247-254